Polymorphonuclear leukocyte integrin profile in vascular atherosclerotic disease

Clinical Hemorheology and Microcirculation

Volumn 30, Issue 1, 2004, Pages 53-60

  Lo Presti, Rosalia ^a   Canino, Baldassare ^a   Montana, Maria ^a   Ferrara, Filippo ^a   Carollo, Caterina ^a   Porretto, Ferdinando ^a   Caimi, Gregorio ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Atherosclerosis; Integrin; Polymorphonuclear leukocyte

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; GLYCOPROTEIN P 15095; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PHORBOL 12 ACETATE 13 MYRISTATE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MALE; NEUTROPHIL; PROTEIN EXPRESSION; UPREGULATION;

AGED; ANTIGENS, CD11A; ANTIGENS, CD11B; ANTIGENS, CD11C; ANTIGENS, CD18; ARTERIOSCLEROSIS; CELL ADHESION; DOWN-REGULATION; FEMALE; HUMANS; INTEGRINS; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; TETRADECANOYLPHORBOL ACETATE; UP-REGULATION;

EID: 1242295253     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. S.M. Albelda and C.A. Buck, Integrins and other cell adhesion molecules, FASEB J. 4 (1990), 2868-2880.
2. M. Arai, D.J. Lefer, T. So, A. DiPaula, T. Aversano and L.C. Becker, An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hours reperfusion, J. Am. Coll. Cardiol. 5 (1996), 1278-1285.
3. T. Aversano, W. Zhou, M. Nedelman, M. Nadada and H. Weisman, A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion, J. Am. Coll. Cardiol. 25 (1995), 781-788.
4. K.W. Baran, M. Nguyen, G.R. McKendall, C.T. Lambrew, G. Dykstra, S.T. Palmeri, R.J. Gibbon, S. Borzak, B.E. Sobel, S.G. Gourlay, A.C. Rundle, C.M. Gibson and H.V. Barron, Double-blind, randomized trial of an anti-CD18 antibody in conjunction with recombinant tissue plasminogen activator for acute myocardial infarction: limitation of myocardial infarction following thrombolysis in acute myocardial infarction (LIMIT AMI) study, Circulation 104 (2001), 2778-2783.
5. J.J.F. Belch, J.W. Shaw, G. Kirk, M. McLaren, R. Robb, C. Maple and P. Morse, The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty, Circulation 95 (1997), 2027-2031.
6. A.D. Blann and C.N. McCollum, Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis, Thromb. Haemost. 72 (1994), 151-154.
7. 2+ content in subjects with vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus, Angiology 47 (1996), 757-763.
8. 2+ content in vascular atherosclerotic disease with and without non-insulin-dependent diabetes mellitus, Clin. Hemorheol. Microcirc. 17 (1997), 429-436.
9. 2+ content in subjects with vascular atherosclerotic disease, Artery 22 (1997), 328-335.
10. 2+ content at baseline and after activation, Clin. Hemorheol. Microcirc. 19 (1998), 281-289.
11. G. Caimi, B. Canino, F. Ferrara, M. Montana, M. Musso, C. Carollo, A. Catania and R. Lo Presti, Granulocyte integrins before and after activation in acute ischaemic stroke, J. Neurol. Sci. 186 (2001), 23-26.
12. G. Caimi, M. Montana, R. Citarrella, F. Porretto, A. Catania and R. Lo Presti, Polymorphonuclear leukocyte integrin profile in diabetes mellitus, Clin. Hemorheol. Microcirc. 27 (2002), 83-89.
13. G. Caimi, M. Montana, F. Ferrara, F. Porretto, M. Musso, B. Canino and R. Lo Presti, Polymorphonuclear leukocyte integrin pattern, at baseline and after activation, in type 2 diabetic subjects with macrovascular complications, Acta Diabetol. 40 (2003), 14-19.
14. 2 integrins by stimulated human neutrophils analyzed by flow cytometry, J. Leuk. Biol. 53 (1993), 462-469.
15. H. Chen, M. Chopp, R.L. Zhang, G. Bodzin, Q. Chen, J.R. Rusche and R.F. Todd III, Ami CD-11b monoclonal antibody reduces ischaemic cell damage after transient focal cerebral ischaemia in rat, Ann. Neurol. 35 (1994), 458-463.
16. M. Chopp, R.L. Zhang, H. Chen, Y. Li, N. Jiang and J.R. Rusche, Postischaemic administration of an anti-Mac-1 antibody reduces ischaemic cell damage after transient middle cerebral artery occlusion in rats, Stroke 25 (1994), 869-876.
17. G. Ciuffetti, R. Lombardini, L. Pasqualini and G. Vaudo, Leukocyte-endothelial interactions in chronic critical limb ischaemia, Ann. It. Med. Int. 11 (1996), 170-174.
18. N. Clausell, K.F. Prado and J.P. Ribeiro, Increased plasma levels of soluble vascular cellular adhesion molecule-1 in patients with chest pain and angiographically normal coronary arteries, Int. J. Cardiol. 68 (1999), 275-280.
19. Z.-M. Ding, J.E. Babensee, S.I. Simon, H. Lu, J.L. Perrard, D.C. Bullard, X.Y. Dai, S.K. Bromley, M.L. Dustin, M.L. Entman, C. Wayne Smith and C.M. Ballantyne, Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration, J. Immunol. 163 (1999), 5029-5038.
20. D.P. Faxon, R.J. Gibbons, N.A.F. Chronos, P.A. Gurbel and F. Sheehan, The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study, J. Am. Coll. Cardiol. 40 (2002), 1199-1204.
21. U. Fiszer, G. Korczak-Kowalska, W. Palasik, J. Kodak, A. Gorski and A. Czlonkowska, Increased expression of adhesion molecule CD18 (LFA-1beta) on the leukocytes of peripheral blood in patients with acute ischaemic stroke, Acta Neurol. Scand. 97 (1998), 221-224.
22. C.J. Frijns, L.J. Kappelle, J. Van Gijn, H.K. Nieuwenhuis, J.J. Sixma and R. Fijnheer, Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis, Stroke 28 (1997), 2214-2218.
23. A. Galante, A. Pietroiusti, A. Magrini, S. Carta, L. Franceschelli, P. Piccolo, G.R. Pistolese, E. Martelli, A. Mastino, C. Matteucci, S. Grelli and C. Favalli, Leukocyte rheological properties are altered in patients with diffuse atherosclerosis, Thromb. Haemost. 77 (1997), 1073-1076.
24. P. Golino, G. Ambrosio, M. Ragni, P. Cirillo, N. Esposito, J.T. Willerson, R. Rothlein, L. Petrucci, M. Condorelli, M. Chiariello and L.M. Buja, Inhibition of leukocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury, Thromb. Haemost. 77 (1997), 783-788.
25. J.M. Harlan, Leukocyte-endothelial interactions, Blood 65 (1985), 513-525.
26. P.E. Hughes, F. Díaz-González, L. Leong, C. Wu, J.A. McDonald, S.J. Shattil and M.H. Ginsberg, Breaking the integrin hinge: A defined structural constraint regulates integrin signaling, J. Biol. Chem. 271 (1996), 6571-6574.
27. S.J. Hwang, C.M. Ballantyne, A.R. Sharrett, L.C. Smith, C.E. Davis, A.M.Jr. Gotto and E. Boerwinkle, Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study, Circulation 96 (1997), 4219-4225.
28. T. Inoue, Y. Sakai, T. Fujito, K. Hoshi, T. Hayashi, K. Takayanagi and S. Morooka, Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis, Thromb. Haemost. 79 (1998), 54-58.
29. T. Inoue, Y. Sakai, K. Hoshi, I. Yaguchi, T. Fujito and S. Morooka, Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty, Circulation 97 (1998), 2511-2518.
30. Y. Jang, A.M. Lincoff, E.F. Plow and E.J. Topol, Cell adhesion molecules in coronary artery disease, J. Am. Coll. Cardiol. 24 (1994), 1591-1601.
31. M. Kassirer, D. Zeltser, V. Prochorov, G. Schoenman, A. Frimerman, G. Keren, I. Shapira, H. Miller, A. Roth, N. Arber and A. Eldor, Berliner S. Increased expression of the CD11b/CD18 antigen on the surface of peripheral white blood cells in patients with ischemic heart disease: further evidence for smoldering inflammation in patients with atherosclerosis, Am. Heart J. 138 (1999), 555-559.
32. D.J. Leahy, New light on the integrin switch, Structure 10 (2002), 1152-1154.
33. S.E. Lennie, G.D.O. Lowe, J.C. Barbenel, C.D. Forbes and W.S. Foulds, Filterability of white blood cell subpopulations, separated by an improved method, Clin. Hemorheol. 7 (1987), 811-816.
34. E. Lindmark, L. Wallentin and A. Siegbahn, Blood cell activation, coagulation, and inflammation in men and women with coronary artery disease, Thromb. Res. 103 (2001), 249-259.
35. I. Malik, J. Danesh, P. Whincup, V. Bhatia, O. Papacosta, M. Walker, L. Lennon, A. Thomson and D. Haskard, Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis, Lancet 358 (2001), 971-975.
36. M. Masuda, Y. Komiyama, T. Murakami, K. Murata, M. Hasui, Y. Hirabayashi and Y. Kobayashi, Difference in changes of membrane fluidity of polymorphonuclear leukocytes stimulated with phorbol myristate acetate and formyl-methionyl-leucyl-phenylalanine: role of excited oxygen species, J. Leukoc. Biol. 47 (1990), 105-110.
37. S.R. Meisel, H. Shapiro, J. Radnay, Y. Neuman, A.-R. Khaskia, N. Gruener, H. Pauzner and D. David, Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction, J. Am. Coll. Cardiol. 31 (1998), 120-125.
38. J.K. Mickelson, N.M. Lakkis, G. Villarreal-Levy, B.J. Hughes and C.W. Smith, Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?, J. Am. Coll. Cardiol. 28 (1996), 345-353.
39. J. Mikita, G. Nash and J. Dormandy, A simple method of preparing white blood cells for filterability testing, Clin. Hemorheol. 6 (1986), 635-639.
40. F.-J. Neumann, I. Ott, M. Gawaz, G. Richardt, H. Holzapfel, M. Jochum and A. Schomig, Cardiac release of cytokines and inflammatory responses in acute myocardial infarction, Circulation 92 (1995), 748-755.
41. T. Okulla, S. Gass, K. Bohme, K. Tiemann, U. Harbrecht, T. Klockgether and C. Pohl, Circulating adhesion molecules in patients with internal carotid artery stenosis, Cerebrovasc. Dis. 14 (2002), 9-14.
42. A.J. Palazzo, S.P. Jones, W.G. Giron, D.C. Anderson, D.N. Granger and D.J. Lefer, Myocardial ischemia-reperfusion injury in CD18 and ICAM-1 deficient mice, Am. J. Physiol. 275 (1998), H2300-H2307.
43. K. Peter, P. Nawroth, C. Conradt, T. Nordt, T. Weiss, M. Boehme, A. Wunsch, J. Allenberg, W. Kubler and C. Bode, Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin, Arterioscler. Thromb. Vasc. Biol. 17 (1997), 505-512.
44. A.D. Pradhan, N. Rifai and P.M. Ridker, Soluble intercellular adhesion molecule-1, soluble vascular adhesion moleucule-1, and the development of symptomatic peripheral arterial disease in men, Circulation 106 (2002), 820-825.
45. P. Sánchez-Mateos, C. Cabañas and F. Sánchez-Madrid, Regulation of integrin function, Semin. Cancer. Biol. 7 (1996), 99-109.
46. S.G. Soriano, A. Coxon, Y.F. Wang, M.P. Frosch, S.A. Lipton, P.R. Hickey and T.N. Mayadas, Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischaemia/reperfusion injury, Stroke 30 (1999), 134-139.
47. D. Tschoepe, Adhesion molecules influencing atherosclerosis, Diabetes Res. Clin. Pract. 30(Suppl.) (1996), 19-24.
48. N.H. Wallén, C. Held, N. Rehnqvist and P. Hjemdahl, Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction, Eur. Heart J. 20 (1999), 1039-1043.
49. K. Yasui, M. Masuda, T. Matsuoka, M. Yamazaki, A. Komiyama, T. Akabane, M. Hasui, Y. Kobayashi and K. Murata, Abnormal membrane fluidity as a cause of impaired dynamics of chemoattractant receptors on neonatal polymorphonuclear leukocytes: lack of modulation of the receptors by a membrane fluidizer, Pediatr. Res. 24 (1988), 442-446.
50. M. A. Yenari, D. Kunis, G.H. Sun, D. Onley, L. Watson, S. Turner, S. Whitaker and G.K. Steinberg, Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin reduces injury in a rabbit model of transient focal cerebral ischaemia, Exp. Neurol. 153 (1998), 223-233.
51. H. Zeitler, Y. Ko, C. Zimmermann, G. Nickenig, K. Glänzer, P. Walger, A. Sachinidis and H. Vetter, Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction, Eur. J. Med. Res. 2 (1997), 389-394.